1. DISEASE CHARACTERISTICS 1.1 Name of the disease (synonyms) 3-M syndrome (gloomy face syndrome, dolichospondylic dysplasia).
1.2 OMIM# of the disease 273750.
1.3 Name of the analysed genes or DNA/chromosome segments CUL7, OBSL1 and CCDC8. [1] [2] [3] [4] [5] 1.4 OMIM# of the gene(s) 609577 (CUL7), 610991 (OBSL1) and 614145 (CCDC8).
Mutational spectrum
CUL7: predominance of null mutations (nonsense and splice site but missense also frequent). Fifty percent of CUL7 mutations are located in the cullin domain critical for anchoring the ROC1 protein; the others are located throughout the gene. Major gene involved in 75% of 3-M cases. OBSL1: mutations within the first eight exons affecting all known isoforms, with a predominance of loss-of-function mutations. Prevalent mutation c.1273insA (p.T245fs*40) identified in 12/23 families with OBSL1 mutations. CCDC8: comprises a single exon. Mutations generate truncated CCDC8 with subsequent loss of function.
1.6 Analytical methods CUL7: genomic DNA extracted from peripheral blood. Ensembl reference sequence: ENSG00000044090: 23 primers to amplify 25 coding exons, purifying with exonuclease I and sequencing.
OBSL1: genomic DNA extracted from peripheral blood. Ensembl reference sequence: ENSG00000124006: intronic primers for each of the 22 exons. PCR amplification and sequencing.
CCDC8: genomic DNA extracted from peripheral blood. Ensembl reference sequence: ENSG00000169515: one single exon. PCR amplification and sequencing. 
Negative predictive value:
2.1 Analytical sensitivity (proportion of positive tests if the genotype is present) Not applicable.
Analytical specificity (proportion of negative tests if the genotype is not present)
Not applicable.
Clinical sensitivity (proportion of positive tests if the disease is present)
The clinical sensitivity can be dependent on variable factors such as age or family history. In such cases a general statement should be given, even if a quantification can only be made case by case. 80-90% due to genetic heterogeneity.
Clinical specificity (proportion of negative tests if the disease is not present)
The clinical specificity can be dependent on variable factors such as age or family history. In such cases a general statement should be given, even if a quantification can only be made case by case.
Positive clinical predictive value (life-time risk to develop the disease if the test is positive)
The disease is antenatally present. (Not applicable) 2.6 Negative clinical predictive value (probability not to develop the disease if the test is negative) Assume an increased risk based on family history for a non-affected person. Allelic and locus heterogeneity may need to be considered.
(Not applicable) Index case in that family had been tested: (Not applicable) Index case in that family had not been tested: (Not applicable) 3. CLINICAL UTILITY 3.1 (Differential) diagnostics: The tested person is clinically affected (To be answered if in 1.10 'A' was marked) Molecular testing for 3M syndrome is clinically indicated if the following suggestive features are present:
Short stature with prenatal onset. Recent reports provide details on heights by genotype and GH-IGF status. [6] [7] [8] The range of height restriction is indeed variable and not always as severe as previously reported in the literature.
Typical facial features including a relatively large head, triangular face, hypoplastic midface, full eyebrows, fleshy nose tip, long philtrum, prominent mouth and lips, and pointed chin. Facial appearance varies among affected individuals.
Additional features such as a short broad neck, prominent trapezii, deformed sternum, short thorax, square shoulders, winged scapulae, hyperlordosis, dislocated hips/hip dysplasia, short fifth fingers, prominent heels and joint hypermobility.
Male hypogonadism and hypospadias can be associated, although not always.
Radiographic findings, although they may not be present, include the following:
Long bones are slender with diaphyseal constriction and flared metaphyses, which seem to be the main radiologic features of the 3-M syndrome. Increased radiolucency is unusual. 9 The metacarpal index, used to document slender long bones, is usually high.
Vertebral bodies are tall with reduced anterior-posterior and transverse diameter, especially in the lumbar region. Foreshortening of the vertebral bodies becomes more apparent with increasing age. Calculation of the vertebral index at different ages reveals that the vertebral index of L1 is a useful tool to document the 3-M syndrome, although tall vertebrae are a nonspecific finding that may be secondary to hypotonia. Anterior wedging of thoracic vertebral bodies, irregular upper and lower endplates, thoracic kyphoscoliosis and spina bifida occulta may also be features of the 3-M syndrome.
Pelvic bones are small, especially the pubis and the ischium. The iliac wings are flared and the obturator foramina are small, although the latter may be positional. The femoral necks can be short.
Thorax is broad with slender and horizontal ribs. Bone age is slightly delayed. Other findings include dolichocephaly, flattening of the forehead due to fusion of the coronal sutures, narrowed interorbital distance, elbow dysplasia, shortened ulna, pseudo-epiphyses of the second metacarpal bone, clinodactyly of the little fingers, dislocated hips and prominent talus.
DIFFERENTIAL DIAGNOSIS Russel-Silver syndrome (RSS): characterised by intrauterine growth retardation accompanied by postnatal growth deficiency. The birth weight of affected individuals is typically two or more SD below the mean, and postnatal growth two or more SD below the mean for length or height. Affected individuals typically have proportionately short stature, normal head circumference, typical facial features and limb length asymmetry that may result from hemihypotrophy with diminished growth of the affected side. About 10% of individuals with RSS will have maternal disomy for chromosome 7 and up to another 50% will have abnormal methylation at the imprinting control centre on chromosome 11 (H19 and IGF-1). Body asymmetry is not usually seen in 3-M syndrome. The radiographic findings of 3-M are not seen in RSS. RSS is sporadic, whereas 3-M is autosomal recessively inherited. A recent report demonstrated that children thought to have autosomal recessive RSS did in fact have 3-M syndrome. 10 Dubowitz syndrome: includes characteristic facial appearance (small face with sloping forehead, broad nasal bridge, shallow supraorbital ridge, broad nasal tip, short palpebral fissures, telecanthus, ptosis and dysplastic ears), microcephaly, mental deficiency, and infantile eczema as well as prenatal and postnatal growth deficiency. Although Dubowitz syndrome is also inherited in an autosomal recessive manner, it can be differentiated from 3M by the presence of typical facial features, eczema, microcephaly and developmental delay.
Mulibrey nanism: includes prenatal and postnatal growth deficiency with relatively large hands, triangular facies with frontal bossing and depressed nasal bridge, small tongue, yellowish dots on the fundus and pericardial constriction. Elongated sella turcica and cystic bone changes of the tibiae are also seen. These findings differentiate it from the 3-M syndrome clinically and radiographically. The gene responsible for this disorder is TRIM37. 11 Mulibrey nanism is inherited in an autosomal recessive manner.
Fetal alcohol syndrome: microcephaly-decreased subcutaneous fat, hirsutism, nail hypoplasia, facial appearance and mental retardation with significant behavioural problems are the primary features, and these allow differentiation from 3-M syndrome. A history of antenatal exposure to excess alcohol is also present.
Can a diagnosis be made other than through a genetic test?
No & (continue with 3. 
Prenatal diagnosis
(To be answered if in 1.10 'D' was marked) Prenatal testing may be available for families in which the diseasecausing mutations have been identified in an affected family member. 3-M syndrome should also be considered if ultrasound examination reveals significant slowing of long bone growth. 12 3.4.1 Does a positive genetic test result in the index patient enable a prenatal diagnostic? Yes.
IF APPLICABLE, FURTHER CONSEQUENCES OF TESTING
Please assume that the result of a genetic test has no immediate medical consequences. Is there any evidence that a genetic test is nevertheless useful for the patient or his/her relatives? (Please describe)
Yes for management, treatment, prenatal diagnosis and genetic counselling. Other differential diagnoses can then be ruled out. It is generally reassuringly informative that the disease has been identified.
